Results 161 to 170 of about 70,632 (264)

Advances in Electrocardiogram‐Based Non‐Invasive Blood Glucose Monitoring Technology

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Blood glucose monitoring is fundamental to diabetes management, yet traditional invasive methods are limited by patient discomfort and infection risks. In recent years, electrocardiogram (ECG), a conventional tool for cardiovascular assessment, has gained attention as a prospective method for non‐invasive blood glucose monitoring.
Qi Zeng, Jiaying Ni, Ziyi Zhang, Jinghao Cai, Jingyi Lu, Jian Zhou   +5 more
wiley   +1 more source

Association between glycated hemoglobin levels and changes in aqueous humor inflammatory cytokines during sequential cataract surgeries in patients with type 2 diabetes mellitus: A retrospective study. [PDF]

Medicine (Baltimore)
He J, Li X, Gong R.
europepmc   +1 more source

Cardio‐Kidney‐Metabolic Therapy Use Among Adults With Type 1 Diabetes and Chronic Kidney Disease

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Kidney and cardiovascular diseases are highly prevalent among patients with Type 1 diabetes. To date, no randomised clinical trial has reported on the impact of novel cardio‐kidney‐metabolic (CKM) therapies (GLP‐1RA and SGLT2i) on kidney function in this population.
M. Luiza Caramori, Enrico Repetto, Christopher Perkins, Ambarish Pandey, Peter Rossing   +4 more
wiley   +1 more source

Fasting plasma glucose performs better than glycated hemoglobin and glycated albumin for diagnosing gestational diabetes. [PDF]

Int J Gynaecol Obstet
Khambule L, Chauke L, Crowther NJ, George JA.   +3 more
europepmc   +1 more source

Demographic Change in Prevalent Type 1 Diabetes Adult Population, and Association of Risk Factors With Comorbidities and Mortality—Results From the Finnish Diabetes Control Study FinDiCon

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims The objective was to characterise Finnish adults with type 1 diabetes (T1D) and to explore associations between known risk factors, comorbidities and mortality. Materials and Methods Individuals with T1D in 2014–2021 were identified from national health care registers, and data on medication and comorbidities were combined with laboratory
Hannu Vessari, Tuire Prami, Essi J. Peltonen, Elina Pimiä, Ilona Iso‐Mustajärvi, Marita Kalaoja, Hanne Luoto, Ilkka Vauhkonen, Tero Saukkonen   +8 more
wiley   +1 more source

Glycated Hemoglobin and Cardiovascular Disease in Patients Without Diabetes. [PDF]

J Clin Med
Jakubiak GK, Chwalba A, Basek A, Cieślar G, Pawlas N.   +4 more
europepmc   +1 more source

Evaluation of evolocumab on saphenous vein graft patency following coronary artery bypass graft surgery in people living with and without diabetes in the NEWTON‐CABG CardioLink‐5 trial

Diabetes, Obesity and Metabolism, EarlyView.
Hwee Teoh, Subodh Verma, G. B. John Mancini, Adrian Quan, Michael Szarek, Randi Elituv, Meena Verma, Elizabeth Misner, Aishwarya Krishnaraj, Peter Jüni, Michael J. Koren, Stephen J. Nicholls, Deepak L. Bhatt, C. David Mazer, Lawrence A. Leiter   +14 more
wiley   +1 more source

A Type 2 Diabetes Policy Model That Predicts Remaining Life Expectancy, Quality‐Adjusted Life Expectancy and Healthcare Costs for Use in Economic Evaluation, Incorporating Equity Concerns

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To illustrate a T2DM policy model incorporating socio‐economic status. Materials and Methods Using the Scottish Diabetes Research Network (SDRN) national diabetes cohort, we identified individuals newly diagnosed with T2DM between 1 January 2004 and 31 December 2020 and followed from diagnosis until death or end of follow‐up.
Lili Wei, Houra Haghpanahan, Sarah H. Wild, Claudia Geue, Elaine Butterly, Peter McMeekin, Stuart McGurnaghan, Luke A. K. Blackbourn, Robert Lindsay, David McAllister, Jim Lewsey   +10 more
wiley   +1 more source

Interplay of glycated hemoglobin and traditional risk factors for the risk of atherosclerotic cardiovascular disease and all-cause mortality in people without diabetes. [PDF]

Cardiovasc Diabetol
Masrouri S, Hasanpour A, Ebrahimi N, Hadaegh F.   +3 more
europepmc   +1 more source

Cost‐Effectiveness of Automated Insulin Delivery Systems in Paediatrics, T1D and T2D Adults Across Four Nordic Countries

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims This study evaluated long‐term cost‐effectiveness of automated insulin delivery (AID) systems versus multiple daily injections (MDI) + CGM in children with type 1 diabetes (T1D), adults with T1D and insulin‐treated individuals with type 2 diabetes (T2D) across Denmark, Finland, Norway and Sweden.
Johan Jendle, Kirsten Nørgaard, Elina Pimiä, Heiko Bratke, Aesha Khan Mirón, Maria‐Eleni Syleouni   +5 more
wiley   +1 more source